Suchergebnisse - "Bouhnik, Y"

PubPharm (222)

1

Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator : a Multicentre Cohort Study

enthalten in: Journal of Crohn's & colitis | 2022

von Poullenot, F. | Amiot, A. | Nachury, M. | +17

2

Defining and Assessing the Reproducibility of Crohn's Disease Endoscopic Lesions : A Delphi-like Method from the GETAID

enthalten in: Journal of Crohn's & colitis | 2021

von Buisson, A. | Filippi, J. | Amiot, A. | +19

3

What is the outcome for patients undergoing more than two ileocolonic resections for recurrent Crohn's disease? A comparative study of 569 consecutive procedures

enthalten in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland | 2019

von Bouquot, M. | Maggiori, L. | Hain, E. | +3

4

Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess : a multicentre, prospective, observational cohort study

enthalten in: Journal of Crohn's & colitis | 2019

von Pineton de Chambrun, G. | Pariente, B. | Seksik, P. | +20

5

What is the outcome for patients undergoing more than two ileocolonic resections for recurrent Crohn's disease? A comparative study of 569 consecutive procedures

enthalten in: Colorectal Disease | 2019

von Bouquot, M. | Maggiori, L. | Hain, E. | +3

6

An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Rieder, F. | Bettenworth, D. | Ma, C. | +18

CommentIn: Aliment Pharmacol Ther. 2018 Dec;48(11-12):1312-1313. - PMID 30488631

7

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients : a multicentre experience

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Wils, P. | Bouhnik, Y. | Michetti, P. | +19

8

Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease : a multicentre cohort study nested in the OBSERV-IBD cohort

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Tadbiri, S. | Peyrin-Biroulet, L. | Serrero, M. | +95

9

Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab

enthalten in: Gut | 2018

von Laharie, D. | Bourreille, A. | Branche, J. | +28

10

One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease : a prospective multicentre cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2017

von Amiot, A. | Serrero, M. | Peyrin-Biroulet, L. | +91

CommentIn: Aliment Pharmacol Ther. 2017 Sep;46(5):555-556. - PMID 28776739

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]